Vimedimex Medi-Pharma JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Cash & Equivalents	128,642	301,122	209,806	213,681	148,753
Short-Term Investments	224,900	33,960	39,649	42,695	31,158
Cash & Short-Term Investments	353,542	335,082	249,455	256,375	179,911
Cash Growth	5.51%	34.33%	-2.70%	42.50%	-46.13%
Accounts Receivable	20,343	307,165	646,417	1,141,641	2,000,498
Other Receivables	62,651	199,624	406,871	163,986	163,544
Receivables	82,994	506,790	1,053,288	1,305,626	2,164,042
Inventory	19,475	84,864	247,076	947,132	2,531,669
Prepaid Expenses	-	1,706	1,617	4,175	2,896
Other Current Assets	-	47,861	62,826	299,011	401,119
Total Current Assets	456,011	976,303	1,614,262	2,812,320	5,279,637
Property, Plant & Equipment	44,500	110,781	134,506	132,700	146,847
Long-Term Investments	7,931	8,991	7,931	7,931	6,551
Other Intangible Assets	15,161	31,827	17,313	18,168	18,818
Long-Term Deferred Tax Assets	-	-	-	-	94.93
Other Long-Term Assets	1,648,644	69,552	76,284	82,402	79,558
Total Assets	2,172,247	1,197,455	1,850,296	3,053,522	5,531,506
Accounts Payable	159,884	598,383	1,063,506	1,908,699	4,183,257
Accrued Expenses	-	20,147	9,797	17,043	221,264
Short-Term Debt	-	-	-	-	612,374
Current Income Taxes Payable	8,934	5,931	3,489	5,880	-
Current Unearned Revenue	-	-	224.02	151.5	-
Other Current Liabilities	108,270	137,870	332,149	682,301	94,179
Total Current Liabilities	277,089	762,331	1,409,165	2,614,073	5,111,074
Other Long-Term Liabilities	1,362,127	18,470	20,077	20,746	23,664
Total Liabilities	1,639,216	780,800	1,429,242	2,634,819	5,134,738
Common Stock	154,403	154,403	154,403	154,403	154,403
Additional Paid-In Capital	114,168	114,168	114,168	114,168	114,168
Retained Earnings	98,596	59,418	64,348	71,623	53,266
Comprehensive Income & Other	7,338	9,262	9,262	9,262	8,206
Total Common Equity	374,506	337,251	342,181	349,456	330,042
Minority Interest	158,525	79,404	78,873	69,246	66,726
Shareholders' Equity	533,031	416,654	421,054	418,702	396,768
Total Liabilities & Equity	2,172,247	1,197,455	1,850,296	3,053,522	5,531,506
Total Debt	-	-	-	-	612,374
Net Cash (Debt)	353,542	335,082	249,455	256,375	-432,463
Net Cash Growth	5.51%	34.33%	-2.70%	-	-
Net Cash Per Share	22897.43	21701.83	16152.32	16604.34	-28008.76
Filing Date Shares Outstanding	15.44	15.44	15.44	15.44	15.44
Total Common Shares Outstanding	15.44	15.44	15.44	15.44	15.44
Working Capital	178,922	213,972	205,097	198,247	168,563
Book Value Per Share	24255.14	21842.28	22161.60	22633.91	21375.44
Tangible Book Value	359,345	305,423	324,868	331,288	311,224
Tangible Book Value Per Share	23273.25	19780.96	21040.32	21457.18	20156.64
Buildings	23,376	78,941	77,896	77,896	79,708
Machinery	25,843	120,033	120,033	108,504	108,463
Construction In Progress	32,242	33,905	46,972	41,385	40,563

Source: S&P Global Market Intelligence. Standard template. Financial Sources.